The authors describe a simplified technique for a "ureter-intestinal graft" antireflux anastomosis in cystoprostatectomy, with immediate replacement of the ureter by an intestinal graft, using Camey's procedure.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
Similar Publications
[Palliative surgery for metastatic prostate cancer].
Urologie
March 2024
Klinik für Urologie, Uro-Onkologie, roboter-assistierte und spezielle urologische Chirurgie, Uniklinik Köln, Kerpener Str. 62, 50937, Köln, Deutschland.
Article Synopsis
- The standard treatment for metastatic hormone-sensitive prostate cancer (mHSPC) includes androgen deprivation therapy along with drugs like docetaxel and abiraterone, while low-risk patients can benefit from additional radiation or surgery.
- Despite initial positive responses to treatment, almost all patients will eventually develop castration-resistant prostate cancer (CRPC) within 2.5 to 4 years, leading to the need for secondary treatments and management of complications.
- As survival rates improve, uro-oncologists need to focus more on managing local progression symptoms and complications, utilizing surgical methods like palliative TURP, cystectomy, or urinary diversion techniques to address issues like urinary obstruction or fistulas.
[Palliative urologic surgery for metastatic prostate cancer: what needs to be considered in the future?].
Aktuelle Urol
April 2024
Klinik für Urologie, Uro-Onkologie, spezielle urologische und Roboter-assistierte Chirurgie, Universitätsklinikum Köln, Köln, Germany.
Androgen deprivation in combination with novel hormonal agents, docetaxel or the combination of abiraterone/prednisone plus docetaxel or darolutamide plus docetaxel represent the standard therapeutic approach in metastatic hormone-sensitive prostate cancer (mHSPC). Patients with low-risk prostate cancer also benefit from additional radiation therapy or radical prostatectomy in terms of progression-free and overall survival. Despite favourable response rates, basically all patients will develop castration-resistant prostate cancer (CRPC) within 2.
View Article and Find Full Text PDFSignet-ring cell sinus histiocytosis: report of the clinicopathologic characteristics of 4 cases with emphasis on the differential diagnosis of signet-ring cell lesions.
Hum Pathol
September 2023
Department of Pathology, The Ohio State University Wexner Medical Center, James Cancer Hospital and Solove Research Institute, Columbus, OH, 43210, USA.
Signet-ring cell sinus histiocytosis (SRCSH) represents a distinctly rare reactive phenomenon predominantly affecting axillary and pelvic lymph nodes (LNs) of individuals with breast or prostatic adenocarcinoma. Reports of SRCSH in the literature are sparse with only 12 previous examples, thus underscoring the rarity of this process. Here, we report 4 additional SRCSH cases affecting 2 women and 2 men (M/F = 1:1; age range: 50-71 years; mean age = 61 years).
View Article and Find Full Text PDFNeobladder creation is still a conduit to peritoneal dialysis - Successful use of peritoneal dialysis after invasive bladder cancer.
Perit Dial Int
July 2022
Department of Medicine, University of Ottawa, Ottawa, ON, Canada.
Peritoneal dialysis (PD) is as safe and more cost-effective than haemodialysis (HD). It also allows patients to undergo renal replacement therapy (RRT) from home. However, PD remains underutilised in many parts of the world.
View Article and Find Full Text PDFHyperchloremic metabolic acidosis can be a problem in urinary diversion using the ileum. A 73-year-old Japanese male was hospitalized in emergency due to anorexia and malaise 3 weeks after being discharged from the hospital after getting robot-assisted radical cystoprostatectomy and intracorporeal ileal conduit urinary diversion. The blood analysis revealed metabolic acidosis, elevated chloride ions, and marked hyperglycemia: he was diagnosed with hyperchloremic metabolic acidosis and hyperglycemic hyperosmolar syndrome.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!